ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ 4
4 · ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ · Filed Jan 4, 2008
Insider Transaction Report
Form 4
ROUSE JAMES E
DirectorPresident & CEO
Transactions
- Award
Stock Options
2008-01-02+9,500→ 9,500 totalExercise: $7.15Exp: 2014-01-02→ Common Stock (9,500 underlying)
Footnotes (2)
- [F1]The option holder may exercise purchase rights for 1,900 shares on or after 1/2/2009, and 1,900 each on or after anniversary date each year until 9,500 shares are exercised.
- [F2]The consideration for the options is the option holder's future service to the company.